Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Coya Therapeutics Inc.

    NASDAQ: COYA · Real-Time Price · USD
    5.81
    -0.09 (-1.53%)
    At close: Jun 27, 2025, 3:59 PM
    6.14
    5.68%
    After-hours: Jun 27, 2025, 05:29 PM EDT

    Coya Therapeutics Statistics

    Share Statistics

    Coya Therapeutics has 16.72M shares outstanding. The number of shares has increased by 9.88% in one year.

    Shares Outstanding

    n/a
    		 16.72M

    Shares Change (YoY)

    n/a
    		 9.88%

    Shares Change (QoQ)

    n/a
    		 0.11%

    Owned by Institutions (%)

    n/a
    		 29.16%

    Shares Floating

    n/a
    		 15.55M

    Failed to Deliver (FTD) Shares

    n/a
    		 794

    FTD / Avg. Volume

    n/a
    		 1.38%

    Short Selling Information

    The latest short interest is 287.43K, so 1.72% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 287.43K

    Short % of Shares Out

    n/a
    		 1.72%

    Short % of Float

    n/a
    		 1.85%

    Short Ratio (days to cover)

    n/a
    		 8.95

    Valuation Ratios

    The PE ratio is -5.87 and the forward PE ratio is -3.04. Coya Therapeutics's PEG ratio is -0.24.

    PE Ratio

    n/a
    		 -5.87

    Forward PE

    n/a
    		 -3.04

    PS Ratio

    n/a
    		 24.57

    Forward PS

    n/a
    		 3.2

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 -8.49

    PEG Ratio

    n/a
    		 -0.24
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Coya Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 11585.5, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 11585.5

    Quick Ratio

    n/a
    		 11585.5

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $444,250

    Profits Per Employee

    n/a
    		 $-1,860,125

    Employee Count

    n/a
    		 8

    Asset Turnover

    n/a
    		 0.08

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -720K

    Effective Tax Rate

    n/a
    		 4.62%

    Stock Price Statistics

    The stock price has increased by -3.12% in the last 52 weeks. The beta is 0.21, so Coya Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.21

    52-Week Price Change

    n/a
    		 -3.12%

    50-Day Moving Average

    n/a
    		 5.84

    200-Day Moving Average

    n/a
    		 6.31

    Relative Strength Index (RSI)

    n/a
    		 55.16

    Average Volume (20 Days)

    n/a
    		 57,479

    Income Statement

    In the last 12 months, Coya Therapeutics had revenue of 3.55M and earned -14.88M in profits. Earnings per share was -0.98.

    Revenue

    n/a
    		 3.55M

    Gross Profit

    n/a
    		 3.55M

    Operating Income

    n/a
    		 -17.25M

    Net Income

    n/a
    		 -14.88M

    EBITDA

    n/a
    		 -17.22M

    EBIT

    n/a
    		 -17.23M

    Earnings Per Share (EPS)

    n/a
    		 -0.98
    Full Income Statement

    Balance Sheet

    The company has 38.34M in cash and 0 in debt, giving a net cash position of 38.34M.

    Cash & Cash Equivalents

    n/a
    		 38.34M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -40.74B

    Total Assets

    n/a
    		 38.4B

    Working Capital

    n/a
    		 34.03B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -10.29M and capital expenditures 0, giving a free cash flow of -10.29M.

    Operating Cash Flow

    n/a
    		 -10.29M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -10.29M

    FCF Per Share

    n/a
    		 -0.68
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -485.35% and -418.7%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -485.35%

    Pretax Margin

    n/a
    		 -438.96%

    Profit Margin

    n/a
    		 -418.7%

    EBITDA Margin

    n/a
    		 -484.58%

    EBIT Margin

    n/a
    		 -485.37%

    FCF Margin

    n/a
    		 -289.5%

    Dividends & Yields

    COYA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for COYA is $18, which is 205.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $18

    Price Target Difference

    n/a
    		 205.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -0.68

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist